Genex Pharmaceutical, Inc. (OTCPK: GENX)
Health Care · Health Care Equipment & Supplies · CN
$—
— today · — 1Y
Genex Pharmaceutical, Inc. (OTCPK: GENX) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $1.78K and employs 86 people.
trading between 0.00 and 0.00.
Tweenvest scores Genex Pharmaceutical, Inc. across four factors: value 50/100. Its strongest factor is value.
GENX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.78K
- Revenue (TTM)
- $3.24M
- P/E
- 0.01
- EPS
- 0.02
- Dividend yield
- —
- Beta (5Y)
- -50.34
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 17.85M
- Employees
- 86
- Next earnings
- —
About Genex Pharmaceutical, Inc.
Genex Pharmaceutical, Inc. engages in the development and production of Reconstituted Bone Xenograft, which is a medical device that accelerates bone healing. The company was founded on February 28, 2002 and is headquartered in Tianjin, China.
- ISIN
- US37227T1051
- Founded
- 2003
- Listed since
- Mar 29, 2004
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $116.23 | +0.09% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $372.61 | +0.21% |
| Stryker CorporationNYSE: SYK | $126.81B | $332.01 | +0.43% |
| Medtronic plcNYSE: MDT | $116.66B | $91.23 | +0.10% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €160.65 | +0.94% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $46.98 | -5.78% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.87 | +0.41% |
Figures last refreshed Aug 18, 2026.